FDA has regulatory authority over health aspects of tobacco products, says SC

Q: How long will it take to read this news story?

The story "FDA has regulatory authority over health aspects of tobacco products, says SC" has 573 words across 19 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "FDA has regulatory authority over health aspects of tobacco products, says SC" was covered 16 hours ago by Business Mirror, a news publisher based in Philippines.

Q: How trustworthy is 'Business Mirror' news outlet?

Business Mirror is a fully independent (privately-owned) news outlet established in 2005 that covers mostly business and startups news. The outlet is headquartered in Philippines and publishes an average of 89 news stories per day. It's most recent story was published 16 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Positive, indicating that people regard this as "good news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21875376</li><li>URL: https://beamstart.com/news/fda-has-regulatory-authority-over-17224493425892</li></ul>

Business Mirror Logo Business Mirror 16h ago

FDA has regulatory authority over health aspects of tobacco products, says SC - Business Mirror

Quick Summary:

The Department of Health (DOH) has recognized as a "significant victory” for public health the recent decision of the Supreme Court (SC) affirming the regulatory authority of the Food and Drug Administration (FDA) over the health aspects of tobacco products in the country.

While lauding the SC decision, the DOH stressed that it is a decisive step against the tobacco industry’s attempt to “circumvent regulations.

The Parents Against Vape has been consistently calling on our lawmakers to amend the law and return the regulatory power to FDA,” Rebie Relator, president of PAV, said.